001 | 982169 | ||
005 | 20250207132722.0 | ||
024 | 7 | _ | |2 HSB |a eva544424 |
024 | 7 | _ | |2 ISSN |a 2234-943X |
024 | 7 | _ | |2 SCOPUS |a SCOPUS:2-s2.0-85175806708 |
024 | 7 | _ | |2 WOS |a WOS:001170573400001 |
024 | 7 | _ | |2 datacite_doi |a 10.18154/RWTH-CONV-252232 |
024 | 7 | _ | |2 doi |a 10.3389/fonc.2023.1277453 |
024 | 7 | _ | |2 pmid |a pmid:37941547 |
037 | _ | _ | |a RWTH-CONV-252232 |
041 | _ | _ | |a English |
100 | 1 | _ | |0 P:(DE-82)943030 |a Olschok, Kathrin |b 0 |u rwth |
245 | _ | _ | |a The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling |h online |
260 | _ | _ | |a Lausanne |b Frontiers Media |c 2023 |
300 | _ | _ | |a 1-13 |
336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |
336 | 7 | _ | |0 PUB:(DE-HGF)7 |2 PUB:(DE-HGF) |a Contribution to a book |
336 | 7 | _ | |2 BibTeX |a ARTICLE |
336 | 7 | _ | |2 DRIVER |a article |
336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
591 | _ | _ | |a Germany |
700 | 1 | _ | |0 P:(DE-588)1250519136 |a Altenburg, Bianca |b 1 |u rwth |
700 | 1 | _ | |0 P:(DE-588)1238644163 |a de Toledo, Marcelo A. S. |b 2 |u rwth |
700 | 1 | _ | |0 P:(DE-588)124497403X |a Maurer, Angela |b 3 |u rwth |
700 | 1 | _ | |0 P:(DE-82)849946 |a Abels, Anne |b 4 |u rwth |
700 | 1 | _ | |0 P:(DE-588)138749027 |a Beier, Fabian |b 5 |u rwth |
700 | 1 | _ | |0 P:(DE-82)958140 |a Gezer, Deniz |b 6 |u rwth |
700 | 1 | _ | |0 P:(DE-82)136034 |a Isfort, Susanne |b 7 |u rwth |
700 | 1 | _ | |a Paeschke, Katrin |b 8 |
700 | 1 | _ | |0 P:(DE-82)IDM06025 |a Brümmendorf, Tim Henrik |b 9 |u rwth |
700 | 1 | _ | |0 P:(DE-82)IDM00384 |a Zenke, Martin |b 10 |u rwth |
700 | 1 | _ | |0 P:(DE-82)042776 |a Chatain, Nicolas |b 11 |e Corresponding author |u rwth |
700 | 1 | _ | |0 P:(DE-82)IDM06178 |a Koschmieder, Steffen |b 12 |e Corresponding author |u rwth |
770 | _ | _ | |a Biological and Clinical Implications of the Mutational Landscape in Myeloproliferative Neoplasms |
773 | _ | _ | |0 PERI:(DE-600)2649216-7 |a 10.3389/fonc.2023.1277453 |p 1277453 |t Frontiers in oncology |v 13 |x 2234-943X |
856 | 4 | _ | |u https://publications.rwth-aachen.de/record/982169/files/982169.pdf |y OpenAccess |
909 | C | O | |o oai:publications.rwth-aachen.de:982169 |p openaire |p open_access |p driver |p dnbdelivery |p VDB |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)943030 |a RWTH Aachen |b 0 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-588)1250519136 |a RWTH Aachen |b 1 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-588)1238644163 |a RWTH Aachen |b 2 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-588)124497403X |a RWTH Aachen |b 3 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)849946 |a RWTH Aachen |b 4 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-588)138749027 |a RWTH Aachen |b 5 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)958140 |a RWTH Aachen |b 6 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)136034 |a RWTH Aachen |b 7 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM06025 |a RWTH Aachen |b 9 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM00384 |a RWTH Aachen |b 10 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)042776 |a RWTH Aachen |b 11 |k RWTH |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM06178 |a RWTH Aachen |b 12 |k RWTH |
914 | 1 | _ | |y 2023 |
915 | 1 | _ | |0 StatID:(DE-HGF)0031 |2 StatID |a Peer reviewed article |x 0 |
915 | _ | _ | |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |a Creative Commons Attribution CC BY 4.0 |
915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b FRONT ONCOL : 2022 |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0113 |2 StatID |a WoS |b Science Citation Index Expanded |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0160 |2 StatID |a DBCoverage |b Essential Science Indicators |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0320 |2 StatID |a DBCoverage |b PubMed Central |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0500 |2 StatID |a DBCoverage |b DOAJ |d 2021-05-11T13:25:45Z |
915 | _ | _ | |0 StatID:(DE-HGF)0501 |2 StatID |a DBCoverage |b DOAJ Seal |d 2021-05-11T13:25:45Z |
915 | _ | _ | |0 StatID:(DE-HGF)0510 |2 StatID |a OpenAccess |
915 | _ | _ | |0 StatID:(DE-HGF)0561 |2 StatID |a Article Processing Charges |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)0700 |2 StatID |a Fees |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)1110 |2 StatID |a DBCoverage |b Current Contents - Clinical Medicine |d 2023-10-26 |
915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |d 2023-10-26 |
920 | 1 | _ | |0 I:(DE-82)531040-2_20140620 |k 531040-2 |l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie) |x 0 |
970 | _ | _ | |a eva544424 |
980 | 1 | _ | |a FullTexts |
980 | _ | _ | |a I:(DE-82)531040-2_20140620 |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a VDB |
980 | _ | _ | |a contb |
980 | _ | _ | |a journal |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|